Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 6.45571780 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.45571780 |
3 | L-phenylalanine metabolic process (GO:0006558) | 6.13439304 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.13439304 |
5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.91234056 |
6 | alpha-linolenic acid metabolic process (GO:0036109) | 5.88038964 |
7 | bile acid biosynthetic process (GO:0006699) | 5.67392845 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 5.66829948 |
9 | urea cycle (GO:0000050) | 5.61985096 |
10 | urea metabolic process (GO:0019627) | 5.61985096 |
11 | nuclear pore complex assembly (GO:0051292) | 5.55429973 |
12 | glyoxylate metabolic process (GO:0046487) | 5.21190908 |
13 | cysteine metabolic process (GO:0006534) | 5.17187753 |
14 | negative regulation of fibrinolysis (GO:0051918) | 5.17103041 |
15 | high-density lipoprotein particle remodeling (GO:0034375) | 5.15003315 |
16 | kynurenine metabolic process (GO:0070189) | 5.10056999 |
17 | nitrogen cycle metabolic process (GO:0071941) | 5.01982773 |
18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.99826019 |
19 | complement activation, alternative pathway (GO:0006957) | 4.98639861 |
20 | sulfur amino acid catabolic process (GO:0000098) | 4.95898236 |
21 | nuclear pore organization (GO:0006999) | 4.94708375 |
22 | indole-containing compound catabolic process (GO:0042436) | 4.94546733 |
23 | indolalkylamine catabolic process (GO:0046218) | 4.94546733 |
24 | tryptophan catabolic process (GO:0006569) | 4.94546733 |
25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.88354054 |
26 | protein carboxylation (GO:0018214) | 4.88354054 |
27 | lysine catabolic process (GO:0006554) | 4.82793339 |
28 | lysine metabolic process (GO:0006553) | 4.82793339 |
29 | regulation of protein activation cascade (GO:2000257) | 4.81634119 |
30 | bile acid metabolic process (GO:0008206) | 4.79241001 |
31 | regulation of NFAT protein import into nucleus (GO:0051532) | 4.77783654 |
32 | pore complex assembly (GO:0046931) | 4.75315722 |
33 | regulation of fibrinolysis (GO:0051917) | 4.75069712 |
34 | tryptophan metabolic process (GO:0006568) | 4.74407541 |
35 | serine family amino acid catabolic process (GO:0009071) | 4.69828080 |
36 | regulation of triglyceride catabolic process (GO:0010896) | 4.56993239 |
37 | homocysteine metabolic process (GO:0050667) | 4.55765489 |
38 | reverse cholesterol transport (GO:0043691) | 4.54233589 |
39 | regulation of complement activation (GO:0030449) | 4.48764112 |
40 | macromolecular complex remodeling (GO:0034367) | 4.46677531 |
41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.46677531 |
42 | protein-lipid complex remodeling (GO:0034368) | 4.46677531 |
43 | amino-acid betaine metabolic process (GO:0006577) | 4.45783144 |
44 | tyrosine metabolic process (GO:0006570) | 4.36810972 |
45 | protein localization to endosome (GO:0036010) | 4.35980552 |
46 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.34501118 |
47 | acylglycerol homeostasis (GO:0055090) | 4.33772479 |
48 | triglyceride homeostasis (GO:0070328) | 4.33772479 |
49 | plasma lipoprotein particle clearance (GO:0034381) | 4.33651522 |
50 | response to muramyl dipeptide (GO:0032495) | 4.28923018 |
51 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.26600313 |
52 | mitotic sister chromatid cohesion (GO:0007064) | 4.21297800 |
53 | alpha-amino acid catabolic process (GO:1901606) | 4.18888204 |
54 | cellular ketone body metabolic process (GO:0046950) | 4.15967595 |
55 | regulation of cholesterol esterification (GO:0010872) | 4.09192698 |
56 | positive regulation of lipid catabolic process (GO:0050996) | 4.08612421 |
57 | ethanol oxidation (GO:0006069) | 4.05635699 |
58 | aromatic amino acid family metabolic process (GO:0009072) | 4.04021782 |
59 | negative regulation of cholesterol transport (GO:0032375) | 4.03595138 |
60 | negative regulation of sterol transport (GO:0032372) | 4.03595138 |
61 | phospholipid efflux (GO:0033700) | 4.03364545 |
62 | phospholipid homeostasis (GO:0055091) | 4.01892397 |
63 | glutamate metabolic process (GO:0006536) | 3.98934830 |
64 | coenzyme catabolic process (GO:0009109) | 3.96558694 |
65 | glycine metabolic process (GO:0006544) | 3.91379980 |
66 | cholesterol efflux (GO:0033344) | 3.89955286 |
67 | 2-oxoglutarate metabolic process (GO:0006103) | 3.88653039 |
68 | cellular amino acid catabolic process (GO:0009063) | 3.87142479 |
69 | regulation of RNA export from nucleus (GO:0046831) | 3.86736837 |
70 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.82970365 |
71 | plasma lipoprotein particle assembly (GO:0034377) | 3.76043801 |
72 | acetyl-CoA metabolic process (GO:0006084) | 3.74908303 |
73 | cellular glucuronidation (GO:0052695) | 3.74726327 |
74 | drug catabolic process (GO:0042737) | 3.73894030 |
75 | regulation of cholesterol homeostasis (GO:2000188) | 3.73795996 |
76 | cellular modified amino acid catabolic process (GO:0042219) | 3.73624378 |
77 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.71708528 |
78 | serine family amino acid metabolic process (GO:0009069) | 3.70089066 |
79 | short-chain fatty acid metabolic process (GO:0046459) | 3.68883697 |
80 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.68757993 |
81 | fatty acid transmembrane transport (GO:1902001) | 3.67438497 |
82 | ketone body metabolic process (GO:1902224) | 3.66660060 |
83 | response to peptidoglycan (GO:0032494) | 3.66640816 |
84 | imidazole-containing compound metabolic process (GO:0052803) | 3.63712666 |
85 | bile acid and bile salt transport (GO:0015721) | 3.63397513 |
86 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.61726235 |
87 | positive regulation of fatty acid oxidation (GO:0046321) | 3.61376175 |
88 | valine metabolic process (GO:0006573) | 3.56759646 |
89 | aspartate family amino acid catabolic process (GO:0009068) | 3.53757156 |
90 | fatty acid beta-oxidation (GO:0006635) | 3.53466286 |
91 | monocarboxylic acid catabolic process (GO:0072329) | 3.51736228 |
92 | negative regulation of lipase activity (GO:0060192) | 3.51357601 |
93 | carboxylic acid catabolic process (GO:0046395) | 3.50876831 |
94 | organic acid catabolic process (GO:0016054) | 3.50876831 |
95 | indolalkylamine metabolic process (GO:0006586) | 3.50213475 |
96 | fatty acid oxidation (GO:0019395) | 3.49978491 |
97 | protein-lipid complex assembly (GO:0065005) | 3.48422131 |
98 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.48277968 |
99 | embryonic process involved in female pregnancy (GO:0060136) | 3.46947533 |
100 | plasma lipoprotein particle organization (GO:0071827) | 3.46609408 |
101 | low-density lipoprotein particle remodeling (GO:0034374) | 3.44736262 |
102 | fibrinolysis (GO:0042730) | 3.44645235 |
103 | benzene-containing compound metabolic process (GO:0042537) | 3.44242015 |
104 | lipid oxidation (GO:0034440) | 3.42931657 |
105 | histone H3-K36 demethylation (GO:0070544) | 3.42525401 |
106 | arginine metabolic process (GO:0006525) | 3.37385746 |
107 | serine family amino acid biosynthetic process (GO:0009070) | 3.36880252 |
108 | cholesterol homeostasis (GO:0042632) | 3.33333643 |
109 | lipoprotein metabolic process (GO:0042157) | 3.32760845 |
110 | protein-lipid complex subunit organization (GO:0071825) | 3.32470012 |
111 | cellular extravasation (GO:0045123) | 3.32226675 |
112 | sterol homeostasis (GO:0055092) | 3.31308203 |
113 | fatty acid catabolic process (GO:0009062) | 3.30672306 |
114 | carnitine metabolic process (GO:0009437) | 3.28513532 |
115 | cellular response to arsenic-containing substance (GO:0071243) | 3.25550110 |
116 | mitotic chromosome condensation (GO:0007076) | 3.24346443 |
117 | positive regulation of cell cycle checkpoint (GO:1901978) | 3.21321435 |
118 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.20555478 |
119 | mRNA stabilization (GO:0048255) | 3.08300076 |
120 | RNA stabilization (GO:0043489) | 3.08300076 |
121 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.99054655 |
122 | dosage compensation (GO:0007549) | 2.98202228 |
123 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.97643057 |
124 | negative regulation of inclusion body assembly (GO:0090084) | 2.94915531 |
125 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.94475329 |
126 | histone demethylation (GO:0016577) | 2.84666272 |
127 | histone lysine demethylation (GO:0070076) | 2.83388860 |
128 | peptidyl-lysine dimethylation (GO:0018027) | 2.77538421 |
129 | DNA synthesis involved in DNA repair (GO:0000731) | 2.75716082 |
130 | negative regulation of myotube differentiation (GO:0010832) | 2.74420221 |
131 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.71630877 |
132 | regulation of histone H3-K27 methylation (GO:0061085) | 2.69425218 |
133 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.66387397 |
134 | response to laminar fluid shear stress (GO:0034616) | 2.65444226 |
135 | negative regulation of histone methylation (GO:0031061) | 2.61046918 |
136 | peptidyl-threonine phosphorylation (GO:0018107) | 2.60619834 |
137 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.60223078 |
138 | activation of Rac GTPase activity (GO:0032863) | 2.59898763 |
139 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.57417941 |
140 | ER overload response (GO:0006983) | 2.56963119 |
141 | protein localization to chromosome, centromeric region (GO:0071459) | 2.56818696 |
142 | N-terminal protein amino acid acetylation (GO:0006474) | 2.56531431 |
143 | coronary vasculature morphogenesis (GO:0060977) | 2.55239975 |
144 | germinal center formation (GO:0002467) | 2.53827202 |
145 | response to nerve growth factor (GO:1990089) | 2.50519141 |
146 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.50519141 |
147 | protein dealkylation (GO:0008214) | 2.48336448 |
148 | protein demethylation (GO:0006482) | 2.48336448 |
149 | sister chromatid cohesion (GO:0007062) | 2.47768979 |
150 | peptidyl-threonine modification (GO:0018210) | 2.45645016 |
151 | histone H2B ubiquitination (GO:0033523) | 2.43717525 |
152 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.42628833 |
153 | regulation of macrophage cytokine production (GO:0010935) | 2.42312849 |
154 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.42180195 |
155 | positive regulation of macrophage cytokine production (GO:0060907) | 2.41619242 |
156 | positive regulation by symbiont of host defense response (GO:0052509) | 2.41103615 |
157 | modulation by symbiont of host defense response (GO:0052031) | 2.41103615 |
158 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.41103615 |
159 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.41103615 |
160 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.41103615 |
161 | modulation by symbiont of host immune response (GO:0052553) | 2.41103615 |
162 | definitive hemopoiesis (GO:0060216) | 2.40824018 |
163 | stress fiber assembly (GO:0043149) | 2.39625734 |
164 | regulation of leukocyte degranulation (GO:0043300) | 2.36813119 |
165 | detection of molecule of bacterial origin (GO:0032490) | 2.36809722 |
166 | DNA unwinding involved in DNA replication (GO:0006268) | 2.36499242 |
167 | histone H3-K9 demethylation (GO:0033169) | 2.35368653 |
168 | histone H2A monoubiquitination (GO:0035518) | 2.35188575 |
169 | heart valve formation (GO:0003188) | 2.34483307 |
170 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.33944723 |
171 | negative regulation of type 2 immune response (GO:0002829) | 2.31969592 |
172 | DNA topological change (GO:0006265) | 2.30220976 |
173 | mitotic metaphase plate congression (GO:0007080) | 2.29702853 |
174 | protein export from nucleus (GO:0006611) | 2.28845979 |
175 | establishment of chromosome localization (GO:0051303) | 2.28745390 |
176 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.28654518 |
177 | cellular protein complex localization (GO:0034629) | 2.28328093 |
178 | regulation of ARF protein signal transduction (GO:0032012) | 2.28009737 |
179 | histone monoubiquitination (GO:0010390) | 2.27943698 |
180 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.25685098 |
181 | positive regulation of macroautophagy (GO:0016239) | 2.25107899 |
182 | regulation of histone H3-K9 methylation (GO:0051570) | 2.24459668 |
183 | histone H4 deacetylation (GO:0070933) | 2.22826041 |
184 | positive regulation of protein export from nucleus (GO:0046827) | 2.21950561 |
185 | negative regulation of DNA repair (GO:0045738) | 2.21827426 |
186 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.21551339 |
187 | adenosine receptor signaling pathway (GO:0001973) | 2.20934642 |
188 | mRNA transcription (GO:0009299) | 2.19082886 |
189 | Golgi transport vesicle coating (GO:0048200) | 2.18229666 |
190 | COPI coating of Golgi vesicle (GO:0048205) | 2.18229666 |
191 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.18048170 |
192 | regulation of mRNA stability (GO:0043488) | 2.17364976 |
193 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.17099986 |
194 | cell-substrate adherens junction assembly (GO:0007045) | 2.16955377 |
195 | focal adhesion assembly (GO:0048041) | 2.16955377 |
196 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.14985074 |
197 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.14706408 |
198 | N-terminal protein amino acid modification (GO:0031365) | 2.14658713 |
199 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.14582119 |
200 | macrophage activation involved in immune response (GO:0002281) | 2.14136806 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.40494929 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.30302270 |
3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.07751694 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.73019194 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 5.68797822 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.35228466 |
7 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.92448074 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.63778164 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.94113160 |
10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.89434949 |
11 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.76816302 |
12 | MYC_22102868_ChIP-Seq_BL_Human | 3.37304742 |
13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.18496433 |
14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.84263248 |
15 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 2.63169461 |
16 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.57825135 |
17 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.50207317 |
18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.45693089 |
19 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.44313570 |
20 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.32241332 |
21 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.29163178 |
22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27818891 |
23 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.19501652 |
24 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 2.14881953 |
25 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.09850780 |
26 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.09146866 |
27 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08122102 |
28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.04273309 |
29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.3903816 |
30 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.99655744 |
31 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.95214090 |
32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.92265303 |
33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.91036454 |
34 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.88723505 |
35 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.86481354 |
36 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.85645722 |
37 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.84127569 |
38 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.83964786 |
39 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.81906205 |
40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.80533235 |
41 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.78495775 |
42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.77348187 |
43 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.76801710 |
44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75521765 |
45 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.71939987 |
46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.71374169 |
47 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.68261409 |
48 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.65977417 |
49 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.65421942 |
50 | * PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.63706320 |
51 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.62040753 |
52 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.61921397 |
53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.61267998 |
54 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.59648225 |
55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.56402287 |
56 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.54309911 |
57 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.53526152 |
58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49307622 |
59 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.46507893 |
60 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.46507893 |
61 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.46507893 |
62 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.46462865 |
63 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.44224658 |
64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40740778 |
65 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.39750175 |
66 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.39298411 |
67 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.37908753 |
68 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.36714653 |
69 | KDM2B_26808549_Chip-Seq_K562_Human | 1.33509782 |
70 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.33377349 |
71 | * MAF_26560356_Chip-Seq_TH1_Human | 1.31366002 |
72 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.30856559 |
73 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.30420598 |
74 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30021633 |
75 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.27383811 |
76 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.26700349 |
77 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.24010716 |
78 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.22057033 |
79 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18572264 |
80 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.16456471 |
81 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.15566219 |
82 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.15254903 |
83 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.14446880 |
84 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.13817981 |
85 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.13696180 |
86 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.13296593 |
87 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12457436 |
88 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.12369183 |
89 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.12106669 |
90 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11572950 |
91 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.11265091 |
92 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.09974883 |
93 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.09797875 |
94 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09616579 |
95 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.09404176 |
96 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.08741279 |
97 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.08675993 |
98 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.06646227 |
99 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.05206264 |
100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.05121995 |
101 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04709229 |
102 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03756950 |
103 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.03754598 |
104 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01596403 |
105 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.01440827 |
106 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.00421025 |
107 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.99392973 |
108 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.98669552 |
109 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.98669552 |
110 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95631089 |
111 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95139633 |
112 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.95139054 |
113 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.94985573 |
114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94107489 |
115 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.94099884 |
116 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93458483 |
117 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92069138 |
118 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92069138 |
119 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.92051872 |
120 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90506572 |
121 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90156370 |
122 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90142440 |
123 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.88422300 |
124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88041353 |
125 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.87612684 |
126 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.85985643 |
127 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85707465 |
128 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.85519183 |
129 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84330530 |
130 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.81960873 |
131 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80104863 |
132 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.79932569 |
133 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.79713470 |
134 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.76484682 |
135 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.76481991 |
136 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.75702549 |
137 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.75495492 |
138 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.75495492 |
139 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.74761518 |
140 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74221355 |
141 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.73992170 |
142 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.73848018 |
143 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.72706926 |
144 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72666084 |
145 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.68918610 |
146 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.68417655 |
147 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67953138 |
148 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.67803925 |
149 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.67185995 |
150 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66562032 |
151 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.63656417 |
152 | CBP_21632823_ChIP-Seq_H3396_Human | 0.61335166 |
153 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.57953705 |
154 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.56252635 |
155 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.56189585 |
156 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.56155488 |
157 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.55598086 |
158 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55588079 |
159 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.55370956 |
160 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.54722697 |
161 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.54568523 |
162 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.54434735 |
163 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.53896533 |
164 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.53336346 |
165 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.52616381 |
166 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.52000848 |
167 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.51925114 |
168 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.51760297 |
169 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.50920288 |
170 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.50651835 |
171 | RXR_22108803_ChIP-Seq_LS180_Human | 0.50299567 |
172 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.49394915 |
173 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.49257249 |
174 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.48250805 |
175 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.48250805 |
176 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.47609955 |
177 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.46842202 |
178 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.46790609 |
179 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.44714548 |
180 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.44696798 |
181 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.44516362 |
182 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.43856221 |
183 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.43613214 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.02151908 |
2 | MP0005360_urolithiasis | 7.03107547 |
3 | MP0005365_abnormal_bile_salt | 6.00442622 |
4 | MP0005085_abnormal_gallbladder_physiolo | 5.76778792 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.61913128 |
6 | MP0008057_abnormal_DNA_replication | 4.24995506 |
7 | MP0002009_preneoplasia | 3.88836347 |
8 | MP0010329_abnormal_lipoprotein_level | 3.82062045 |
9 | MP0003252_abnormal_bile_duct | 3.75970142 |
10 | MP0003806_abnormal_nucleotide_metabolis | 3.30129982 |
11 | MP0008260_abnormal_autophagy | 3.15333577 |
12 | MP0005083_abnormal_biliary_tract | 2.77296938 |
13 | MP0003705_abnormal_hypodermis_morpholog | 2.69331320 |
14 | MP0002822_catalepsy | 2.65429898 |
15 | MP0003195_calcinosis | 2.60890073 |
16 | MP0009840_abnormal_foam_cell | 2.55695716 |
17 | MP0005332_abnormal_amino_acid | 2.44202351 |
18 | MP0003828_pulmonary_edema | 2.33078593 |
19 | MP0010352_gastrointestinal_tract_polyps | 2.31202697 |
20 | MP0001666_abnormal_nutrient_absorption | 2.29571975 |
21 | MP0003091_abnormal_cell_migration | 2.22911478 |
22 | MP0002118_abnormal_lipid_homeostasis | 2.15391957 |
23 | MP0003191_abnormal_cellular_cholesterol | 2.10892945 |
24 | MP0000609_abnormal_liver_physiology | 2.10698080 |
25 | MP0005058_abnormal_lysosome_morphology | 2.09334720 |
26 | MP0004130_abnormal_muscle_cell | 2.08506641 |
27 | MP0003303_peritoneal_inflammation | 2.06174261 |
28 | MP0009278_abnormal_bone_marrow | 2.05860482 |
29 | MP0002396_abnormal_hematopoietic_system | 2.03903521 |
30 | MP0004808_abnormal_hematopoietic_stem | 1.97905366 |
31 | MP0008007_abnormal_cellular_replicative | 1.97159089 |
32 | MP0003077_abnormal_cell_cycle | 1.95426617 |
33 | MP0010094_abnormal_chromosome_stability | 1.85478433 |
34 | MP0003566_abnormal_cell_adhesion | 1.73820445 |
35 | MP0005319_abnormal_enzyme/_coenzyme | 1.71948750 |
36 | MP0003111_abnormal_nucleus_morphology | 1.63218674 |
37 | MP0005670_abnormal_white_adipose | 1.60186064 |
38 | MP0000733_abnormal_muscle_development | 1.59602779 |
39 | MP0004019_abnormal_vitamin_homeostasis | 1.57487576 |
40 | MP0001730_embryonic_growth_arrest | 1.51269798 |
41 | MP0002166_altered_tumor_susceptibility | 1.49682560 |
42 | MP0003172_abnormal_lysosome_physiology | 1.48307532 |
43 | MP0005621_abnormal_cell_physiology | 1.47980982 |
44 | MP0000350_abnormal_cell_proliferation | 1.47867795 |
45 | MP0003693_abnormal_embryo_hatching | 1.45404827 |
46 | MP0003868_abnormal_feces_composition | 1.43069481 |
47 | MP0003436_decreased_susceptibility_to | 1.34849244 |
48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.34429874 |
49 | MP0002837_dystrophic_cardiac_calcinosis | 1.33503982 |
50 | MP0002998_abnormal_bone_remodeling | 1.33038658 |
51 | MP0001764_abnormal_homeostasis | 1.29460696 |
52 | MP0002088_abnormal_embryonic_growth/wei | 1.29152792 |
53 | MP0004197_abnormal_fetal_growth/weight/ | 1.29096254 |
54 | MP0003984_embryonic_growth_retardation | 1.28747312 |
55 | MP0010630_abnormal_cardiac_muscle | 1.27999605 |
56 | MP0009697_abnormal_copulation | 1.27948092 |
57 | MP0005171_absent_coat_pigmentation | 1.25605314 |
58 | MP0002006_tumorigenesis | 1.23295829 |
59 | MP0003300_gastrointestinal_ulcer | 1.20684682 |
60 | MP0005408_hypopigmentation | 1.20650464 |
61 | MP0005451_abnormal_body_composition | 1.19331282 |
62 | MP0010368_abnormal_lymphatic_system | 1.19035342 |
63 | MP0005380_embryogenesis_phenotype | 1.18302734 |
64 | MP0001672_abnormal_embryogenesis/_devel | 1.18302734 |
65 | MP0002971_abnormal_brown_adipose | 1.17130634 |
66 | MP0002092_abnormal_eye_morphology | 1.16994668 |
67 | MP0000598_abnormal_liver_morphology | 1.14299708 |
68 | MP0003634_abnormal_glial_cell | 1.14156482 |
69 | MP0002138_abnormal_hepatobiliary_system | 1.13667120 |
70 | MP0009053_abnormal_anal_canal | 1.13367891 |
71 | MP0004233_abnormal_muscle_weight | 1.11975240 |
72 | MP0002086_abnormal_extraembryonic_tissu | 1.11939988 |
73 | MP0000747_muscle_weakness | 1.11037805 |
74 | MP0000920_abnormal_myelination | 1.09961729 |
75 | MP0001697_abnormal_embryo_size | 1.09454315 |
76 | MP0004957_abnormal_blastocyst_morpholog | 1.08542118 |
77 | MP0005666_abnormal_adipose_tissue | 1.08404345 |
78 | MP0005248_abnormal_Harderian_gland | 1.07951551 |
79 | MP0009780_abnormal_chondrocyte_physiolo | 1.07629257 |
80 | MP0000604_amyloidosis | 1.06834746 |
81 | MP0002078_abnormal_glucose_homeostasis | 1.05548547 |
82 | MP0001853_heart_inflammation | 1.05435570 |
83 | MP0004484_altered_response_of | 1.03243001 |
84 | MP0005384_cellular_phenotype | 1.02906089 |
85 | MP0000313_abnormal_cell_death | 1.00891503 |
86 | MP0005409_darkened_coat_color | 1.00077533 |
87 | MP0003453_abnormal_keratinocyte_physiol | 0.99743511 |
88 | MP0002080_prenatal_lethality | 0.99075186 |
89 | MP0002876_abnormal_thyroid_physiology | 0.98650092 |
90 | MP0002896_abnormal_bone_mineralization | 0.97262412 |
91 | MP0005334_abnormal_fat_pad | 0.97247943 |
92 | MP0009643_abnormal_urine_homeostasis | 0.96390585 |
93 | MP0001346_abnormal_lacrimal_gland | 0.94064959 |
94 | MP0004270_analgesia | 0.93626154 |
95 | MP0005647_abnormal_sex_gland | 0.92914761 |
96 | MP0002419_abnormal_innate_immunity | 0.92394116 |
97 | MP0004185_abnormal_adipocyte_glucose | 0.89342006 |
98 | MP0005187_abnormal_penis_morphology | 0.86084381 |
99 | MP0005220_abnormal_exocrine_pancreas | 0.84800692 |
100 | MP0001529_abnormal_vocalization | 0.83533236 |
101 | MP0003656_abnormal_erythrocyte_physiolo | 0.82526266 |
102 | MP0003632_abnormal_nervous_system | 0.81676593 |
103 | MP0002697_abnormal_eye_size | 0.81205999 |
104 | MP0005535_abnormal_body_temperature | 0.81162196 |
105 | MP0009763_increased_sensitivity_to | 0.79843234 |
106 | MP0000759_abnormal_skeletal_muscle | 0.79508943 |
107 | MP0000343_altered_response_to | 0.78431830 |
108 | MP0003186_abnormal_redox_activity | 0.78388684 |
109 | MP0001851_eye_inflammation | 0.78299219 |
110 | MP0005423_abnormal_somatic_nervous | 0.78234857 |
111 | MP0002269_muscular_atrophy | 0.77096417 |
112 | MP0003136_yellow_coat_color | 0.76863546 |
113 | MP0004947_skin_inflammation | 0.76134972 |
114 | MP0010234_abnormal_vibrissa_follicle | 0.76126410 |
115 | MP0006036_abnormal_mitochondrial_physio | 0.75389505 |
116 | MP0009672_abnormal_birth_weight | 0.74590515 |
117 | MP0001727_abnormal_embryo_implantation | 0.74410411 |
118 | MP0009642_abnormal_blood_homeostasis | 0.73288389 |
119 | MP0002398_abnormal_bone_marrow | 0.72455075 |
120 | MP0000639_abnormal_adrenal_gland | 0.71712815 |
121 | MP0004883_abnormal_blood_vessel | 0.71303896 |
122 | MP0002133_abnormal_respiratory_system | 0.71227156 |
123 | MP0005388_respiratory_system_phenotype | 0.71227156 |
124 | MP0004510_myositis | 0.70832407 |
125 | MP0003329_amyloid_beta_deposits | 0.70579402 |
126 | MP0001340_abnormal_eyelid_morphology | 0.70287660 |
127 | MP0001661_extended_life_span | 0.69232419 |
128 | MP0003763_abnormal_thymus_physiology | 0.69229096 |
129 | MP0002254_reproductive_system_inflammat | 0.69036428 |
130 | MP0003115_abnormal_respiratory_system | 0.68779126 |
131 | MP0003448_altered_tumor_morphology | 0.67907098 |
132 | MP0005448_abnormal_energy_balance | 0.67741947 |
133 | MP0002085_abnormal_embryonic_tissue | 0.67624584 |
134 | MP0005376_homeostasis/metabolism_phenot | 0.67394749 |
135 | MP0005636_abnormal_mineral_homeostasis | 0.67179386 |
136 | MP0002877_abnormal_melanocyte_morpholog | 0.66662084 |
137 | MP0009115_abnormal_fat_cell | 0.65479123 |
138 | MP0002925_abnormal_cardiovascular_devel | 0.65153287 |
139 | MP0002249_abnormal_larynx_morphology | 0.64728622 |
140 | MP0003890_abnormal_embryonic-extraembry | 0.63779007 |
141 | MP0004859_abnormal_synaptic_plasticity | 0.61842592 |
142 | MP0005266_abnormal_metabolism | 0.60878697 |
143 | MP0005395_other_phenotype | 0.59841204 |
144 | MP0002909_abnormal_adrenal_gland | 0.59674709 |
145 | MP0002168_other_aberrant_phenotype | 0.59054685 |
146 | MP0004782_abnormal_surfactant_physiolog | 0.57190564 |
147 | MP0003011_delayed_dark_adaptation | 0.56725699 |
148 | MP0002090_abnormal_vision | 0.55612308 |
149 | MP0005375_adipose_tissue_phenotype | 0.54821207 |
150 | MP0002970_abnormal_white_adipose | 0.54118506 |
151 | MP0003646_muscle_fatigue | 0.53807920 |
152 | MP0009384_cardiac_valve_regurgitation | 0.53758614 |
153 | MP0009764_decreased_sensitivity_to | 0.53596538 |
154 | MP0000427_abnormal_hair_cycle | 0.52942603 |
155 | MP0003690_abnormal_glial_cell | 0.52043712 |
156 | MP0003953_abnormal_hormone_level | 0.51165651 |
157 | MP0001756_abnormal_urination | 0.51005354 |
158 | MP0001177_atelectasis | 0.48826192 |
159 | MP0008438_abnormal_cutaneous_collagen | 0.48778846 |
160 | MP0004264_abnormal_extraembryonic_tissu | 0.48055008 |
161 | MP0000566_synostosis | 0.47968416 |
162 | MP0006035_abnormal_mitochondrial_morpho | 0.44594334 |
163 | MP0000569_abnormal_digit_pigmentation | 0.43950730 |
164 | MP0003221_abnormal_cardiomyocyte_apopto | 0.43535061 |
165 | MP0004087_abnormal_muscle_fiber | 0.43356383 |
166 | MP0008469_abnormal_protein_level | 0.43225155 |
167 | MP0001915_intracranial_hemorrhage | 0.42853243 |
168 | MP0005076_abnormal_cell_differentiation | 0.42559599 |
169 | MP0000579_abnormal_nail_morphology | 0.42425438 |
170 | MP0003075_altered_response_to | 0.41533200 |
171 | MP0000013_abnormal_adipose_tissue | 0.40663522 |
172 | MP0001944_abnormal_pancreas_morphology | 0.40494479 |
173 | MP0010307_abnormal_tumor_latency | 0.40208625 |
174 | MP0008961_abnormal_basal_metabolism | 0.38803044 |
175 | MP0001324_abnormal_eye_pigmentation | 0.38527810 |
176 | MP0003718_maternal_effect | 0.38287970 |
177 | MP0002060_abnormal_skin_morphology | 0.36679062 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.13563261 |
2 | Intrahepatic cholestasis (HP:0001406) | 6.45953090 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.92709647 |
4 | Xanthomatosis (HP:0000991) | 5.72847750 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.69749902 |
6 | Hypobetalipoproteinemia (HP:0003563) | 5.54889896 |
7 | Prolonged partial thromboplastin time (HP:0003645) | 5.38314330 |
8 | Hyperlipoproteinemia (HP:0010980) | 4.94315384 |
9 | Complement deficiency (HP:0004431) | 4.80614331 |
10 | Epidermoid cyst (HP:0200040) | 4.77673436 |
11 | Hypolipoproteinemia (HP:0010981) | 4.59567462 |
12 | Ketosis (HP:0001946) | 4.47404053 |
13 | Hypoalphalipoproteinemia (HP:0003233) | 4.42234511 |
14 | Hyperammonemia (HP:0001987) | 4.24787552 |
15 | Hypoglycemic coma (HP:0001325) | 4.22053150 |
16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.20530932 |
17 | Hyperglycinemia (HP:0002154) | 4.15383451 |
18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.12872681 |
19 | Joint hemorrhage (HP:0005261) | 3.91154455 |
20 | Abnormality of the intrinsic pathway (HP:0010989) | 3.84736016 |
21 | Hyperglycinuria (HP:0003108) | 3.83743623 |
22 | Ketoacidosis (HP:0001993) | 3.83382507 |
23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.72614285 |
24 | Abnormality of glycine metabolism (HP:0010895) | 3.72614285 |
25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.67321001 |
26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.66756942 |
27 | Hypercholesterolemia (HP:0003124) | 3.60435988 |
28 | Fat malabsorption (HP:0002630) | 3.44831744 |
29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.34685175 |
30 | Abnormality of complement system (HP:0005339) | 3.33947996 |
31 | Abnormality of methionine metabolism (HP:0010901) | 3.30572261 |
32 | Skin nodule (HP:0200036) | 3.27267507 |
33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.11055595 |
34 | Hepatocellular carcinoma (HP:0001402) | 3.08558905 |
35 | Broad face (HP:0000283) | 3.04138218 |
36 | Myocardial infarction (HP:0001658) | 3.00437514 |
37 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.99047874 |
38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.97493478 |
39 | Abnormality of nucleobase metabolism (HP:0010932) | 2.94935603 |
40 | Abnormality of purine metabolism (HP:0004352) | 2.92879467 |
41 | Spontaneous abortion (HP:0005268) | 2.88202450 |
42 | Hyperglycemia (HP:0003074) | 2.87832475 |
43 | Insidious onset (HP:0003587) | 2.81276885 |
44 | Termporal pattern (HP:0011008) | 2.81276885 |
45 | Conjugated hyperbilirubinemia (HP:0002908) | 2.75992753 |
46 | Hyperbilirubinemia (HP:0002904) | 2.71114411 |
47 | Heterotopia (HP:0002282) | 2.70817620 |
48 | Spastic diplegia (HP:0001264) | 2.69707550 |
49 | Hypochromic microcytic anemia (HP:0004840) | 2.67374229 |
50 | Gout (HP:0001997) | 2.66509258 |
51 | Slow saccadic eye movements (HP:0000514) | 2.61456480 |
52 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.60739952 |
53 | Subaortic stenosis (HP:0001682) | 2.60739952 |
54 | Hypoglycemic seizures (HP:0002173) | 2.59448987 |
55 | Papillary thyroid carcinoma (HP:0002895) | 2.58668580 |
56 | Syringomyelia (HP:0003396) | 2.57606314 |
57 | Spinal cord lesions (HP:0100561) | 2.57606314 |
58 | Deep philtrum (HP:0002002) | 2.57096854 |
59 | Abnormality of serum amino acid levels (HP:0003112) | 2.54690271 |
60 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.52638228 |
61 | Abnormal gallbladder morphology (HP:0012437) | 2.51701695 |
62 | Cholelithiasis (HP:0001081) | 2.50182953 |
63 | Neuronal loss in central nervous system (HP:0002529) | 2.47639517 |
64 | Metabolic acidosis (HP:0001942) | 2.43568230 |
65 | Missing ribs (HP:0000921) | 2.42444187 |
66 | Medulloblastoma (HP:0002885) | 2.40386495 |
67 | Cholecystitis (HP:0001082) | 2.39219059 |
68 | Abnormal gallbladder physiology (HP:0012438) | 2.39219059 |
69 | Acanthocytosis (HP:0001927) | 2.38460915 |
70 | Dysmetric saccades (HP:0000641) | 2.38340955 |
71 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.35908489 |
72 | Steatorrhea (HP:0002570) | 2.33777433 |
73 | Mitral stenosis (HP:0001718) | 2.33206780 |
74 | Esophageal varix (HP:0002040) | 2.31684482 |
75 | Bladder neoplasm (HP:0009725) | 2.30409783 |
76 | Bladder carcinoma (HP:0002862) | 2.30409783 |
77 | Peripheral hypomyelination (HP:0007182) | 2.30388457 |
78 | Menstrual irregularities (HP:0000858) | 2.28847677 |
79 | Vertebral arch anomaly (HP:0008438) | 2.27035487 |
80 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.22570769 |
81 | Dicarboxylic aciduria (HP:0003215) | 2.22570769 |
82 | Leiomyosarcoma (HP:0100243) | 2.20542303 |
83 | Uterine leiomyosarcoma (HP:0002891) | 2.20542303 |
84 | Sensorimotor neuropathy (HP:0007141) | 2.19989253 |
85 | Neonatal onset (HP:0003623) | 2.19793113 |
86 | Delayed CNS myelination (HP:0002188) | 2.19505902 |
87 | Supernumerary ribs (HP:0005815) | 2.19150739 |
88 | Decreased motor nerve conduction velocity (HP:0003431) | 2.18773547 |
89 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.16407903 |
90 | Overlapping toe (HP:0001845) | 2.15687039 |
91 | Myoglobinuria (HP:0002913) | 2.15034517 |
92 | Large earlobe (HP:0009748) | 2.13130610 |
93 | Progressive external ophthalmoplegia (HP:0000590) | 2.11925701 |
94 | Embryonal renal neoplasm (HP:0011794) | 2.11899141 |
95 | Acute myeloid leukemia (HP:0004808) | 2.10569147 |
96 | Lower limb amyotrophy (HP:0007210) | 2.09882303 |
97 | Abnormality of the lower motor neuron (HP:0002366) | 2.09517183 |
98 | Upper motor neuron abnormality (HP:0002127) | 2.06555953 |
99 | Abnormal cartilage morphology (HP:0002763) | 2.06297083 |
100 | Abnormality of the gallbladder (HP:0005264) | 2.05415431 |
101 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.03921640 |
102 | Scanning speech (HP:0002168) | 2.03850331 |
103 | Disinhibition (HP:0000734) | 2.03658232 |
104 | Late onset (HP:0003584) | 2.01345740 |
105 | Long eyelashes (HP:0000527) | 2.01305059 |
106 | Hyperacusis (HP:0010780) | 2.00726681 |
107 | Disproportionate tall stature (HP:0001519) | 2.00375204 |
108 | Renal cell carcinoma (HP:0005584) | 1.98958107 |
109 | Hyperuricemia (HP:0002149) | 1.98018309 |
110 | Increased purine levels (HP:0004368) | 1.98018309 |
111 | Turricephaly (HP:0000262) | 1.97992612 |
112 | Arterial tortuosity (HP:0005116) | 1.97573804 |
113 | Vascular calcification (HP:0004934) | 1.95761207 |
114 | Increased nuchal translucency (HP:0010880) | 1.95515369 |
115 | Basal cell carcinoma (HP:0002671) | 1.94799281 |
116 | Cortical dysplasia (HP:0002539) | 1.94024904 |
117 | Apathy (HP:0000741) | 1.93334787 |
118 | Toxemia of pregnancy (HP:0100603) | 1.93121429 |
119 | Enlarged kidneys (HP:0000105) | 1.91927048 |
120 | Lethargy (HP:0001254) | 1.91896550 |
121 | Viral hepatitis (HP:0006562) | 1.91644215 |
122 | Status epilepticus (HP:0002133) | 1.91102742 |
123 | Asymmetry of the thorax (HP:0001555) | 1.90925426 |
124 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.89945243 |
125 | Cerebral edema (HP:0002181) | 1.88814808 |
126 | Relative macrocephaly (HP:0004482) | 1.88679950 |
127 | Arnold-Chiari malformation (HP:0002308) | 1.87610233 |
128 | Flat occiput (HP:0005469) | 1.87421831 |
129 | Global brain atrophy (HP:0002283) | 1.87147275 |
130 | Ankyloglossia (HP:0010296) | 1.86647078 |
131 | Systemic lupus erythematosus (HP:0002725) | 1.86006594 |
132 | Cardiovascular calcification (HP:0011915) | 1.85632877 |
133 | Hemorrhage of the eye (HP:0011885) | 1.84833370 |
134 | Thrombophlebitis (HP:0004418) | 1.84465912 |
135 | Irritability (HP:0000737) | 1.84347255 |
136 | Pancreatitis (HP:0001733) | 1.83975166 |
137 | Subacute progressive viral hepatitis (HP:0006572) | 1.83725384 |
138 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.83646733 |
139 | Truncal obesity (HP:0001956) | 1.82776913 |
140 | Tetraparesis (HP:0002273) | 1.82717888 |
141 | Abnormality of chromosome segregation (HP:0002916) | 1.82663942 |
142 | Abnormality of proline metabolism (HP:0010907) | 1.82414405 |
143 | Hydroxyprolinuria (HP:0003080) | 1.82414405 |
144 | Malnutrition (HP:0004395) | 1.82311616 |
145 | Capillary hemangiomas (HP:0005306) | 1.81852055 |
146 | Gastrointestinal carcinoma (HP:0002672) | 1.81817856 |
147 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.81817856 |
148 | Supranuclear gaze palsy (HP:0000605) | 1.80764786 |
149 | Spontaneous hematomas (HP:0007420) | 1.79207579 |
150 | Acute lymphatic leukemia (HP:0006721) | 1.79103743 |
151 | Cellulitis (HP:0100658) | 1.78337279 |
152 | Dislocated radial head (HP:0003083) | 1.78200907 |
153 | Generalized aminoaciduria (HP:0002909) | 1.77576492 |
154 | Vomiting (HP:0002013) | 1.76864805 |
155 | Low anterior hairline (HP:0000294) | 1.76694623 |
156 | Vascular tortuosity (HP:0004948) | 1.76120256 |
157 | Lymphangioma (HP:0100764) | 1.75509734 |
158 | Proximal tubulopathy (HP:0000114) | 1.75038396 |
159 | Narrow palate (HP:0000189) | 1.75010698 |
160 | Neurofibrillary tangles (HP:0002185) | 1.74828919 |
161 | Insomnia (HP:0100785) | 1.73812038 |
162 | Neoplasm of the heart (HP:0100544) | 1.73412012 |
163 | Poikilocytosis (HP:0004447) | 1.71954904 |
164 | Hypertriglyceridemia (HP:0002155) | 1.71384078 |
165 | Reticulocytosis (HP:0001923) | 1.70703687 |
166 | Renal cortical cysts (HP:0000803) | 1.69477474 |
167 | Exercise-induced muscle cramps (HP:0003710) | 1.69431954 |
168 | Acute hepatic failure (HP:0006554) | 1.68439940 |
169 | Diminished motivation (HP:0000745) | 1.68371184 |
170 | Abnormality of the fingertips (HP:0001211) | 1.68060771 |
171 | Back pain (HP:0003418) | 1.67843626 |
172 | Obsessive-compulsive behavior (HP:0000722) | 1.67141984 |
173 | Cerebral inclusion bodies (HP:0100314) | 1.66198294 |
174 | Abnormality of the radial head (HP:0003995) | 1.65092404 |
175 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.64967103 |
176 | Achilles tendon contracture (HP:0001771) | 1.64621946 |
177 | Facial hemangioma (HP:0000329) | 1.64223201 |
178 | Germ cell neoplasia (HP:0100728) | 1.62173643 |
179 | Smooth philtrum (HP:0000319) | 1.61798640 |
180 | Hypopigmentation of the fundus (HP:0007894) | 1.61757610 |
181 | Inappropriate behavior (HP:0000719) | 1.61401743 |
182 | Deviation of the thumb (HP:0009603) | 1.61358921 |
183 | Upper limb muscle weakness (HP:0003484) | 1.60596176 |
184 | Bowel incontinence (HP:0002607) | 1.59533611 |
185 | Glossoptosis (HP:0000162) | 1.59033584 |
186 | EMG: neuropathic changes (HP:0003445) | 1.58849390 |
187 | Somatic mutation (HP:0001428) | 1.58716261 |
188 | Overgrowth (HP:0001548) | 1.58596311 |
189 | Macroorchidism (HP:0000053) | 1.58337373 |
190 | Urinary urgency (HP:0000012) | 1.57839722 |
191 | Supernumerary nipples (HP:0002558) | 1.57074380 |
192 | Hammertoe (HP:0001765) | 1.55841965 |
193 | Distal lower limb amyotrophy (HP:0008944) | 1.55545400 |
194 | Broad nasal tip (HP:0000455) | 1.54307771 |
195 | Sparse lateral eyebrow (HP:0005338) | 1.53270739 |
196 | Ulnar bowing (HP:0003031) | 1.52198527 |
197 | Urethral obstruction (HP:0000796) | 1.52093108 |
198 | Lower limb muscle weakness (HP:0007340) | 1.52044232 |
199 | Neoplasm of the oral cavity (HP:0100649) | 1.51760622 |
Rank | Gene Set | Z-score |
---|---|---|
1 | LATS1 | 4.74946260 |
2 | PRPF4B | 4.03988053 |
3 | BCKDK | 3.69444651 |
4 | SIK1 | 3.63315887 |
5 | PNCK | 3.17242024 |
6 | TRIB3 | 3.11018943 |
7 | PKN2 | 3.01046273 |
8 | NEK1 | 2.54440105 |
9 | FGFR4 | 2.49377319 |
10 | ERN1 | 2.37996443 |
11 | STK38L | 2.33421251 |
12 | PDK4 | 2.23128822 |
13 | PDK3 | 2.23128822 |
14 | FRK | 2.19456269 |
15 | MAP2K4 | 2.00484430 |
16 | ERBB4 | 1.89671389 |
17 | DAPK2 | 1.87799912 |
18 | TAOK3 | 1.86914697 |
19 | INSRR | 1.84652871 |
20 | RIPK1 | 1.76851117 |
21 | NEK9 | 1.76833081 |
22 | IRAK3 | 1.70044364 |
23 | LATS2 | 1.69490178 |
24 | ICK | 1.55579141 |
25 | PDK2 | 1.54881132 |
26 | RIPK4 | 1.51610299 |
27 | WEE1 | 1.50684614 |
28 | FGFR2 | 1.46268092 |
29 | MAP3K14 | 1.46193060 |
30 | MAP3K2 | 1.45797894 |
31 | EIF2AK3 | 1.36076661 |
32 | CAMK1D | 1.33196470 |
33 | PDGFRA | 1.31759809 |
34 | PTK6 | 1.30558063 |
35 | CDK6 | 1.29453026 |
36 | SGK2 | 1.28642922 |
37 | SGK3 | 1.27946587 |
38 | TSSK6 | 1.27446150 |
39 | STK3 | 1.26085655 |
40 | TTN | 1.24141686 |
41 | ARAF | 1.22726894 |
42 | FLT3 | 1.22716840 |
43 | RAF1 | 1.21227617 |
44 | BLK | 1.18461039 |
45 | PRKD3 | 1.16961260 |
46 | MAP2K2 | 1.15741806 |
47 | MKNK2 | 1.14086799 |
48 | MAP3K10 | 1.13910206 |
49 | MAP3K7 | 1.13038657 |
50 | FGFR3 | 1.11992872 |
51 | MAP3K3 | 1.11430149 |
52 | OBSCN | 1.10078921 |
53 | AKT3 | 1.09517885 |
54 | MST1R | 1.07632180 |
55 | IRAK2 | 1.05445081 |
56 | STK38 | 1.04704865 |
57 | MOS | 1.03987423 |
58 | MAPK11 | 1.01301477 |
59 | DMPK | 0.99031594 |
60 | PIK3CG | 0.98038096 |
61 | CDC7 | 0.97019859 |
62 | JAK2 | 0.92448017 |
63 | CAMK4 | 0.92225590 |
64 | WNK1 | 0.92018516 |
65 | MARK2 | 0.91656211 |
66 | PRKAA1 | 0.90599779 |
67 | FGFR1 | 0.89529203 |
68 | KSR2 | 0.86834866 |
69 | PRKAA2 | 0.84088991 |
70 | NEK6 | 0.83836728 |
71 | TAOK2 | 0.82593068 |
72 | RET | 0.82318956 |
73 | MAP3K4 | 0.82166788 |
74 | SRPK1 | 0.81386868 |
75 | IRAK4 | 0.80074955 |
76 | EEF2K | 0.79756118 |
77 | TBK1 | 0.77338260 |
78 | MAPK7 | 0.76220108 |
79 | MAPK10 | 0.74688378 |
80 | MTOR | 0.73541063 |
81 | BMPR2 | 0.71239037 |
82 | SGK223 | 0.71092819 |
83 | SGK494 | 0.71092819 |
84 | SMG1 | 0.69554336 |
85 | CDK9 | 0.68482610 |
86 | BRAF | 0.67308604 |
87 | NUAK1 | 0.66976844 |
88 | RPS6KL1 | 0.65333619 |
89 | RPS6KC1 | 0.65333619 |
90 | FER | 0.65190326 |
91 | JAK1 | 0.65170827 |
92 | CAMK1G | 0.64746552 |
93 | MAP3K1 | 0.64357510 |
94 | FGR | 0.63353770 |
95 | CAMKK1 | 0.62647511 |
96 | IKBKE | 0.61854385 |
97 | MAP2K1 | 0.61229419 |
98 | BRD4 | 0.61221090 |
99 | ABL2 | 0.60852957 |
100 | PINK1 | 0.60699701 |
101 | RPS6KA1 | 0.59392504 |
102 | CDK4 | 0.59320755 |
103 | EIF2AK1 | 0.59039389 |
104 | CHEK1 | 0.58893172 |
105 | PDGFRB | 0.58605086 |
106 | CHUK | 0.58098339 |
107 | PAK2 | 0.57425884 |
108 | LMTK2 | 0.57349766 |
109 | YES1 | 0.57297949 |
110 | MAP3K6 | 0.55799059 |
111 | PRKCH | 0.55598513 |
112 | EPHA4 | 0.55253993 |
113 | CDK3 | 0.54212445 |
114 | RPS6KA4 | 0.53931524 |
115 | MAP2K3 | 0.53641209 |
116 | IRAK1 | 0.52628058 |
117 | MKNK1 | 0.51827197 |
118 | CDK7 | 0.51743751 |
119 | MAP3K5 | 0.50391558 |
120 | CDC42BPA | 0.50078092 |
121 | CCNB1 | 0.47291311 |
122 | PDPK1 | 0.46179313 |
123 | RPS6KB1 | 0.46086525 |
124 | PDK1 | 0.45370935 |
125 | MELK | 0.44321124 |
126 | PAK6 | 0.43970707 |
127 | PTK2 | 0.43905044 |
128 | ALK | 0.43775108 |
129 | PIM1 | 0.43435065 |
130 | PIK3CA | 0.43100107 |
131 | CSF1R | 0.42924735 |
132 | ZAP70 | 0.42271254 |
133 | CDK1 | 0.41694199 |
134 | PRKACG | 0.41639152 |
135 | MAP3K8 | 0.41398952 |
136 | RPS6KA6 | 0.41088736 |
137 | SIK2 | 0.40091237 |
138 | RPS6KA2 | 0.39838224 |
139 | CDK2 | 0.39568039 |
140 | CDK12 | 0.39356810 |
141 | PLK4 | 0.39332472 |
142 | TAOK1 | 0.39292183 |
143 | SCYL2 | 0.37173252 |
144 | DYRK1B | 0.37030223 |
145 | IGF1R | 0.36990936 |
146 | GSK3A | 0.36704741 |
147 | KSR1 | 0.35778323 |
148 | RPS6KA3 | 0.34989859 |
149 | TYK2 | 0.34810955 |
150 | PRKCZ | 0.34314666 |
151 | TTK | 0.34053170 |
152 | ERBB2 | 0.33042650 |
153 | SGK1 | 0.32925333 |
154 | EGFR | 0.32215499 |
155 | PAK3 | 0.31434772 |
156 | MAP3K9 | 0.28972859 |
157 | PRKACB | 0.24161261 |
158 | MAP3K13 | 0.23958414 |
159 | DDR2 | 0.22801993 |
160 | ERBB3 | 0.22252208 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.54312001 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.82892426 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.51021441 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.14461889 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.09441368 |
6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.75946298 |
7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66033694 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.52050594 |
9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.50908762 |
10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.48069139 |
11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.42841584 |
12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.36551815 |
13 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.16089724 |
14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.15108679 |
15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.12574094 |
16 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.08418504 |
17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.07244475 |
18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.05191464 |
19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.02136619 |
20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.96311286 |
21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.94482375 |
22 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.91951754 |
23 | Peroxisome_Homo sapiens_hsa04146 | 1.91910215 |
24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.89958738 |
25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.82400626 |
26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.74648486 |
27 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.73671104 |
28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.73221041 |
29 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.69103243 |
30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.58663207 |
31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55192057 |
32 | Colorectal cancer_Homo sapiens_hsa05210 | 1.54795887 |
33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.54080741 |
34 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.53154890 |
35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.52513654 |
36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.50734578 |
37 | Bile secretion_Homo sapiens_hsa04976 | 1.50315014 |
38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.50020682 |
39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.49826322 |
40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.49275818 |
41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.46191358 |
42 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.45095863 |
43 | Endometrial cancer_Homo sapiens_hsa05213 | 1.44500987 |
44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.43081213 |
45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.42418984 |
46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.42135442 |
47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.39519177 |
48 | Hepatitis B_Homo sapiens_hsa05161 | 1.39378690 |
49 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.38707657 |
50 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.38629032 |
51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37654921 |
52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36322315 |
53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.34217966 |
54 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.32850596 |
55 | Retinol metabolism_Homo sapiens_hsa00830 | 1.32475199 |
56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.32351813 |
57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32151463 |
58 | Prostate cancer_Homo sapiens_hsa05215 | 1.31893898 |
59 | Histidine metabolism_Homo sapiens_hsa00340 | 1.28946362 |
60 | Cell cycle_Homo sapiens_hsa04110 | 1.26021699 |
61 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.25105056 |
62 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.24537805 |
63 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23678610 |
64 | Other glycan degradation_Homo sapiens_hsa00511 | 1.21506260 |
65 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.21031845 |
66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.20985030 |
67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.20859007 |
68 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18673610 |
69 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.17765781 |
70 | Long-term potentiation_Homo sapiens_hsa04720 | 1.16031279 |
71 | Legionellosis_Homo sapiens_hsa05134 | 1.14673640 |
72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.14020369 |
73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13123673 |
74 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11098548 |
75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.10575046 |
76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.09204279 |
77 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.08585358 |
78 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.06294127 |
79 | Lysine degradation_Homo sapiens_hsa00310 | 1.05529816 |
80 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.04825736 |
81 | ABC transporters_Homo sapiens_hsa02010 | 1.03644800 |
82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.02392667 |
83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.01955920 |
84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.00673611 |
85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.00427505 |
86 | Apoptosis_Homo sapiens_hsa04210 | 0.99592557 |
87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.97323711 |
88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.97124994 |
89 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96978613 |
90 | Leishmaniasis_Homo sapiens_hsa05140 | 0.96291519 |
91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.95160490 |
92 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.94899353 |
93 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.94239329 |
94 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.93851918 |
95 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.92562151 |
96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92196080 |
97 | Tuberculosis_Homo sapiens_hsa05152 | 0.91483895 |
98 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91276430 |
99 | Influenza A_Homo sapiens_hsa05164 | 0.89256913 |
100 | Spliceosome_Homo sapiens_hsa03040 | 0.88865766 |
101 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84519896 |
102 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.84070429 |
103 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.82249027 |
104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.82133093 |
105 | RNA transport_Homo sapiens_hsa03013 | 0.79320866 |
106 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75401096 |
107 | Shigellosis_Homo sapiens_hsa05131 | 0.75339880 |
108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74938528 |
109 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.74903537 |
110 | Salmonella infection_Homo sapiens_hsa05132 | 0.74137017 |
111 | Gap junction_Homo sapiens_hsa04540 | 0.73340862 |
112 | Measles_Homo sapiens_hsa05162 | 0.73159375 |
113 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72897950 |
114 | Melanoma_Homo sapiens_hsa05218 | 0.72821593 |
115 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72797604 |
116 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72621536 |
117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72450427 |
118 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.71912703 |
119 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.69435236 |
120 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.69431730 |
121 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68603541 |
122 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67146135 |
123 | Pathways in cancer_Homo sapiens_hsa05200 | 0.67144033 |
124 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66443694 |
125 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.63843351 |
126 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63809333 |
127 | Hepatitis C_Homo sapiens_hsa05160 | 0.62809418 |
128 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62104427 |
129 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.62088182 |
130 | Insulin resistance_Homo sapiens_hsa04931 | 0.61944504 |
131 | Long-term depression_Homo sapiens_hsa04730 | 0.60966912 |
132 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60482284 |
133 | Endocytosis_Homo sapiens_hsa04144 | 0.59978512 |
134 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59027678 |
135 | Focal adhesion_Homo sapiens_hsa04510 | 0.57953548 |
136 | Lysosome_Homo sapiens_hsa04142 | 0.57822026 |
137 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56658199 |
138 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.56065184 |
139 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.55630678 |
140 | Alcoholism_Homo sapiens_hsa05034 | 0.55490263 |
141 | DNA replication_Homo sapiens_hsa03030 | 0.55338841 |
142 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55063050 |
143 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54473988 |
144 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53181434 |
145 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.50775462 |
146 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.49667189 |
147 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48602853 |
148 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40555105 |
149 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40226355 |
150 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36312508 |
151 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34006991 |
152 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.29129207 |
153 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28702133 |
154 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26323011 |
155 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26191440 |
156 | Prion diseases_Homo sapiens_hsa05020 | 0.24961423 |
157 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.20118776 |
158 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.14537221 |
159 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.13267708 |
160 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.12825784 |
161 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.12140342 |
162 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10645382 |
163 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.10381745 |
164 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.05806246 |
165 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.05496926 |
166 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.03575967 |
167 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.02258731 |
168 | Circadian rhythm_Homo sapiens_hsa04710 | 0.01811322 |
169 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.01219408 |
170 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.01194332 |
171 | Adherens junction_Homo sapiens_hsa04520 | -0.1469504 |
172 | Glioma_Homo sapiens_hsa05214 | -0.1292606 |
173 | Non-small cell lung cancer_Homo sapiens_hsa05223 | -0.1277507 |
174 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.1274983 |
175 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | -0.1188386 |
176 | Amoebiasis_Homo sapiens_hsa05146 | -0.1133489 |
177 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0503127 |
178 | Bladder cancer_Homo sapiens_hsa05219 | -0.0070259 |
179 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.0034063 |